Delivery Order SPE2DR25D3101-SPE2DR26F5S80
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,246.57 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges. The order is scheduled for completion by December 9, 2025, and utilizes firm fixed pricing with no set-aside designation, indicating the award resulted from open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,126.17 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges. The order, which is a child of AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), represents a firm fixed price purchase utilizing competitive procurement procedures with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges totaling $1,519.07 with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a $5,155.59 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges (0.5 mL units). This firm fixed-price contract represents a non-competitive delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges (0.5 ml) under a firm fixed price contract valued at $1,819.68. The contract carries an ultimate completion date of June 3, 2025, and represents a non-competitive, non-set-aside award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges with a contract ceiling value of $3,639.24. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The contract is set to conclude on September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,913.45 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,895.22 to AmerisourceBergen Drug Corp for IMITREX 6 mg/0.5 mL cartridges on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $5,338.68 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges. This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance to be completed by September 25, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges with a ceiling value of $7,278.48. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order is due for completion by June 6, 2025, reflecting the expedited nature of pharmaceutical procurement...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5S80Delivery Order
The Defense Logistics Agency awarded a $5,017.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges. This competitive award, issued without set-aside designation, is scheduled for completion by December 15, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Imitrex, a migraine treatment medication commonly used within military healthcare systems, exemplifies AmerisourceBergen's role in fulfilling specific pharmaceutical needs under its broader global pharmaceutical support framework established through the DLA Troop Support Medical contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/11/25 |